Anteris Technologies (ASX:AVR) said the representatives of the underwriters of its US initial public offering partially exercised the over-allotment option for 78,481 common shares at $6 apiece, less underwriting discounts and commissions of $0.42 per share, according to a Wednesday filing with the Australian bourse.
The representatives are TD Cowen, Barclays, and Cantor. The portion of the over-allotment option that was not exercised lapsed on Jan. 11. Settlement occurred on Jan. 14.
Separately, TD Cowen ceased its market stabilization activities on Jan. 12. During the stabilization period, TD Cowen purchased over 2.1 million common shares for prices ranging from $5.14 to $6 on the Nasdaq market.
Anteris Technologies' shares were up more than 3% in recent Wednesday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。